Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2021)
Praxis Precision Medicines' quarterly Interest & Investment Income came in at $46000.0 in Q1 2021, down 64.06% year-on-year from $128000.0 in Q1 2020, and up 666.67% quarter-over-quarter from $6000.0 in Q4 2020.
Praxis Precision Medicines has reported Interest & Investment Income for 3 years, with the latest figure at $46000.0 in Q1 2021.
- For the quarter ending Q1 2021, Interest & Investment Income fell 64.06% year-over-year to $46000.0; the trailing twelve-month figure through Mar 2021 stood at $181000.0 (changed N/A YoY), and the FY2022 full-year result was $957000.0, up 253.14% from the prior year.
- Interest & Investment Income for Q1 2021 stood at $46000.0, up from $6000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $128000.0 in Q1 2020, with the low at $1000.0 in Q3 2020.
- Average Interest & Investment Income over 3 years is $41833.3, with a median of $34000.0 recorded in 2019.
- Year-over-year, Interest & Investment Income tumbled 97.92% in 2020 and slumped 64.06% in 2021.
- Tracing PRAX's Interest & Investment Income over 3 years: stood at $22000.0 in 2019, then slumped by 72.73% to $6000.0 in 2020, then jumped by 666.67% to $46000.0 in 2021.
- The last three Interest & Investment Income figures came in at $46000.0 (Q1 2021), $6000.0 (Q4 2020), and $1000.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 46,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 128,000.00 |
| Dec 31, 2019 | 22,000.00 |
| Sep 30, 2019 | 48,000.00 |